Key Clinical Points Warm Autoimmune Hemolytic Anemia Warm autoimmune hemolytic
anemia (WAHA) is a chronic, relapsing disease characterized by anemia, reticulocytosis …

Introduction Autoimmune hemolytic anemia (AIHA) is classified according to the direct
antiglobulin test (DAT) and thermal characteristics of the autoantibody into warm and cold …

Autoimmune hemolytic anemia (AIHA) is defined by increased erythrocyte turnover
mediated by autoimmune mechanisms. While corticosteroids remain first-line therapy in …

Autoimmune hemolytic anemia (AIHA) is an acquired heterogeneous autoimmune disorder
characterized by the development of antibodies directed against antigens on autologous …

BACKGROUND The clinical consequences of antibodies to red blood cells (RBCs) have
been studied for a century. Most clinically relevant antibodies can be detected by sensitive in …

Reticulocytes are immature red blood cells (RBCs). Reticulocytes originate in the bone
marrow from the orthochromatic normoblast through nuclear exclusion. They are released …

One hundred-nine cases of autoimmune hemolysis were reviewed to determine the
frequency of reticulocytopenia, the state of the erythroid marrow in reticulocytopenic cases …

BACKGROUND: Hyperhemolysis syndrome (HS) has been well described both in sickle cell
disease (SCD) and non‐SCD patients. The pathogenesis remains unclear. The possible …

Patients with autoimmune haemolytic anaemia (AIHA) frequently have anaemia of sufficient
severity as to require a blood transfusion. However, it is impossible to find compatible blood …

Abstract The World Health Organization estimates that approximately a quarter of the world's
population suffers from anemia, including almost half of preschool-age children. Globally …